The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease
Phase 2
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 250
- Registration Number
- NCT00002324
- Locations
- 🇺🇸
UCSD Treatment Ctr, San Diego, California, United States
🇺🇸Saint Francis Mem Hosp, San Francisco, California, United States
🇺🇸Univ of Utah School of Medicine, Salt Lake City, Utah, United States
An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
Phase 1
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 36
- Registration Number
- NCT00002194
- Locations
- 🇺🇸
South Florida Bioavailability Clinic, Miami, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath